Shanghai Pharmaceuticals Holding Co., Ltd

DB:S1R Stock Report

Market Cap: €8.4b

Shanghai Pharmaceuticals Holding Future Growth

Future criteria checks 2/6

Shanghai Pharmaceuticals Holding is forecast to grow earnings and revenue by 18.8% and 10.3% per annum respectively. EPS is expected to grow by 18.7% per annum. Return on equity is forecast to be 8% in 3 years.

Key information

18.8%

Earnings growth rate

18.7%

EPS growth rate

Healthcare earnings growth23.0%
Revenue growth rate10.3%
Future return on equity8.0%
Analyst coverage

Good

Last updated02 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:S1R - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026343,9526,4762,9186,1847
12/31/2025310,9495,6132,9005,8589
12/31/2024282,0844,9323,2176,9238
9/30/2024272,4164,0253,1915,712N/A
6/30/2024267,1164,1001,2484,108N/A
3/31/2024264,2213,793-7692,381N/A
12/31/2023260,2953,7682,2615,232N/A
9/30/2023254,8784,6004,1897,205N/A
6/30/2023252,8664,5313,7746,938N/A
3/31/2023241,3105,8841,8134,610N/A
12/31/2022231,9815,6172,0584,743N/A
9/30/2022229,4635,423-2,3131,978N/A
6/30/2022222,2945,221-1,6592,334N/A
3/31/2022221,1224,224-4433,671N/A
12/31/2021215,8245,0939435,061N/A
9/30/2021212,5595,3782,0134,571N/A
6/30/2021209,9825,6212,8635,310N/A
3/31/2021203,0615,5783,4856,337N/A
12/31/2020191,9094,4963,8356,845N/A
9/30/2020186,2714,2844,9828,288N/A
6/30/2020181,1564,2374,1187,705N/A
3/31/2020181,0073,9932,1945,277N/A
12/31/2019186,5664,0813,2696,022N/A
9/30/2019182,1003,9082,0304,334N/A
6/30/2019175,7814,1342,1674,077N/A
3/31/2019168,7053,9871,2963,193N/A
12/31/2018159,0843,8811,1923,135N/A
9/30/2018149,4174,2046552,536N/A
6/30/2018140,9473,629N/A2,470N/A
3/31/2018134,1043,541N/A2,368N/A
12/31/2017130,8473,521N/A2,649N/A
9/30/2017129,2793,428N/A2,483N/A
6/30/2017126,8483,389N/A2,401N/A
3/31/2017124,6193,306N/A1,995N/A
12/31/2016120,7653,196N/A1,947N/A
9/30/2016116,9933,155N/A1,989N/A
6/30/2016114,2623,075N/A1,672N/A
3/31/2016109,6673,033N/A1,819N/A
12/31/2015105,5172,877N/A1,349N/A
9/30/2015102,7232,857N/A1,265N/A
6/30/201599,3362,807N/A1,547N/A
3/31/201596,2502,738N/A1,758N/A
12/31/201492,3992,591N/A1,336N/A
9/30/201488,8812,477N/A1,161N/A
6/30/201483,5182,371N/A906N/A
3/31/201479,9072,174N/A667N/A
12/31/201378,2232,214N/A973N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: S1R's forecast earnings growth (18.8% per year) is above the savings rate (0.8%).

Earnings vs Market: S1R's earnings (18.8% per year) are forecast to grow slower than the German market (20.1% per year).

High Growth Earnings: S1R's earnings are forecast to grow, but not significantly.

Revenue vs Market: S1R's revenue (10.3% per year) is forecast to grow faster than the German market (5.5% per year).

High Growth Revenue: S1R's revenue (10.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: S1R's Return on Equity is forecast to be low in 3 years time (8%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y